Scientists have uncovered the precise molecular trigger behind a rare blood-clotting disorder linked to certain COVID-19 vaccines.

D Molecular Therapeutics, Inc. (NASDAQ:FDMT) is one of the top gene therapy stocks to buy according to hedge funds. 4D ...

Researchers at the Weill Institute for Cell and Molecular Biology have uncovered new evidence that two major types of gene-controlling DNA sequences, promoters and enhancers, operate with a shared ...

CRISPR gene drives bias inheritance in pests, advancing population-level control while raising questions about resistance and ...

A new CRISPR-based tool that is directly used on patients' cancer cells can identify genes and regulatory elements driving ...

The UC San Diego honorees in NAI’s 2026 class of Senior Members are Omar Akbari, Brian P. Head, Abdoulaye Ndao, Kenneth ...

Vector-borne diseases (VBDs) represent a critical challenge in infectious disease control due to their complex transmission dynamics, diverse vector ...

Increase in funding for R&D activities, surge in awareness regarding gene therapy, and rise in prevalence of cancer, viral infections, and genetic ...

Genetic medicine is rapidly transforming the landscape of cancer research, offering novel strategies for treating malignancies beyond the capabilities of ...

IITs now offer various programs that do not require JEE scores, such as executive robotics (IIT Delhi), genetic engineering (IIT Guwahati), engineering mathematics (IIT Kharagpur), thermodynamics (IIT ...

Archived copies of the webcasts will be available for up to one year on the “Investors” section of the 4DMT website at https://ir.4dmoleculartherapeutics.com/events .

Genetic modification of viruses has long been used as a strategy to treat and prevent different types of diseases. Specifically, it consists of exploiting certain characteristics of viruses that make ...